Schwann cell interactions with axons and microvessels in diabetic neuropathy

NP Gonçalves, CB Vægter, H Andersen… - Nature Reviews …, 2017 - nature.com
The prevalence of diabetes worldwide is at pandemic levels, with the number of patients
increasing by 5% annually. The most common complication of diabetes is peripheral …

[HTML][HTML] Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis

F Sedel, D Bernard, DM Mock, A Tourbah - Neuropharmacology, 2016 - Elsevier
Progressive multiple sclerosis (MS) is a severely disabling neurological condition, and an
effective treatment is urgently needed. Recently, high-dose biotin has emerged as a …

Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs

AE Olesen, T Andresen, C Staahl, AM Drewes - Pharmacological reviews, 2012 - ASPET
Pain models in animals have shown low predictivity for analgesic efficacy in humans, and
clinical studies are often very confounded, blurring the evaluation. Human experimental pain …

[HTML][HTML] Measurement of axonal excitability: Consensus guidelines

MC Kiernan, H Bostock, SB Park, R Kaji, C Krarup… - Clinical …, 2020 - Elsevier
Measurement of axonal excitability provides an in vivo indication of the properties of the
nerve membrane and of the ion channels expressed on these axons. Axonal excitability …

Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A

R Fledrich, RM Stassart, A Klink, LM Rasch, T Prukop… - Nature medicine, 2014 - nature.com
Duplication of the gene encoding the peripheral myelin protein of 22 kDa (PMP22) underlies
the most common inherited neuropathy, Charcot-Marie-Tooth 1A (CMT1A),,, a disease …

Defining the functional role of NaV1. 7 in human nociception

LA McDermott, GA Weir, AC Themistocleous… - Neuron, 2019 - cell.com
Loss-of-function mutations in Na V 1.7 cause congenital insensitivity to pain (CIP); this
voltage-gated sodium channel is therefore a key target for analgesic drug development …

Long‐term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility

SB Park, CSY Lin, AV Krishnan, D Goldstein… - The …, 2011 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Define
the symptoms of sensory neurotoxicity in oxaliplatin‐treated patients and identify the long …

Beyond faithful conduction: short-term dynamics, neuromodulation, and long-term regulation of spike propagation in the axon

D Bucher, JM Goaillard - Progress in neurobiology, 2011 - Elsevier
Most spiking neurons are divided into functional compartments: a dendritic input region, a
soma, a site of action potential initiation, an axon trunk and its collaterals for propagation of …

Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis

S Vucic, CSY Lin, BC Cheah, J Murray, P Menon… - Brain, 2013 - academic.oup.com
Riluzole, a benzothiazole derivative, has been shown to be effective in prolonging survival
in amyotrophic lateral sclerosis. The mechanisms by which riluzole exerts neuroprotective …

The development and modelling of devices and paradigms for transcranial magnetic stimulation

SM Goetz, ZD Deng - International Review of Psychiatry, 2017 - Taylor & Francis
Magnetic stimulation is a non-invasive neurostimulation technique that can evoke action
potentials and modulate neural circuits through induced electric fields. Biophysical models …